Yazar "Malkan, Ümit Yavuz" için listeleme
-
Acute myeloid leukemia in elderly, unfit patients: Analysis of Turkish AML prospective registry database, on behalf of acute leukemia working group of Turkish society of hematology
Merih Urlu, Selin; Cengiz Seval, Güldane; Erdoğan Yücel, Elçin; Mehtap, Özgür; Yenihayat, Emel Merve; Polat, Merve Gökçen; Malkan, Ümit Yavuz; Karakuş, Volkan (American Society of Hematology, 2023)Objective: Low dose Ara-C and hypomethylating agents (HMAs) - decitabine (DEC) and azacitidine (AZA) - have made it possible to treat more elderly patients with acute myeloid leukemia (AML). Both HMAs demonstrated efficacy ... -
Prospective real-world outcomes of acute myeloid leukemia
Karakuş, Volkan; Iltar, Utku; Yenihayat, Emel Merve; Polat, Merve Gökçen; Çelik, Serhat; Malkan, Ümit Yavuz; Cengiz Seval, Güldane; Alacacıoğlu, İnci (American Society of Hematology, 2023)Background: It is evident that treatment outcomes improve with the clinical studies, in this study we aimed to investigate the demographics and treatment modalities of the acute myeloid leukemia (AML) patients in a large ... -
Single agent vemurafenib or rituximab-vemurafenib combination for the treatment of relapsed/refractory hairy cell leukemia, a multicenter experience
Yiğit Kaya, Süreyya; Mutlu, Yaşa Gül; Malkan, Ümit Yavuz; Mehtap, Özgür; Keklik Karadağ, Fatma; Korkmaz, Gülten; Elverdi, Tuğrul; Saydam, Güray; Özet, Gülsüm; Ar, Muhlis Cem; Melek, Elif; Maral, Senem; Kaynar, Leylagül; Sevindik, Ömür Gökmen (2024)Background: Hairy cell leukemia (HCL) is a rare mature B-cell malignancy that is primarily treated with purine analogues. However, relapse remains a significant challenge, prompting the search for alternative therapies. ...